New research has identified a drug combination that can bypass the cellular defences of neuroblastoma that lead to relapse.

A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that ...

Scientists have discovered a drug combo that may bypass tumor defenses, offering new hope for children with high-risk ...

According to Australia’s Garvan Institute of Medical Research, the drug combination can bypass the cellular defences these ...

A discovery from Australian researchers could lead to better treatment for children with neuroblastoma, a cancer that ...

The cancer occurs commonly in children, and is deadly in nine out of 10 cases when children relapse.

Discovered in the 1990s, the JNK protein, or, to give it its full name, c-Jun NH 2-terminal kinase, was found to be the protein kinase responsible for the phosphorylation of c-Jun at Ser-63 and Ser-73 ...

Morphologic and genomic characterization of circulating tumor cells in patients with metastatic colorectal cancer treated with combinational treatment of andecaliximab, bevacizumab and chemotherapy.

Jun N-terminal kinases (JNKs) and p38 mitogen-activated protein kinases (MAPKs) have important roles in the signalling mechanisms that orchestrate cellular responses to many types of stresses, but ...

Researchers in Australia have identified a drug that can help overcome treatment resistance in relapsed neuroblastoma -- the ...